Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Is BMY A Good Stock To Buy Right Now?’

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Bristol-Myers Squibb Co (BMY) To Sell Senior Notes As Formidable Activist Investor Shows Interest

Bristol-Myers Squibb Co (NYSE:BMY) will sell senior notes that are unsecured worth $1.5 billion. Half of that amount is due in two years at a rate of......(read more)

February 23 - News, Stock Analysis - Comments

Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK), And Other Pharmaceutical Firms All Targeting I-O Segment

Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years. Pharmaceutical firms such as Bristol-Myers......(read more)

February 21 - News, Stock Analysis - Comments

biotech research company, bio-technology companies

Bristol-Myers Squibb Co (BMY) To Share In Sales Of Merck & Co., Inc. (MRK) Keytruda Following Litigation Settlement

Merck & Co., Inc. (NYSE:MRK) has agreed to share a portion of Keytruda sales with Bristol-Myers Squibb Co (NYSE:BMY) and Ono Pharmaceutical Co., Ltd......(read more)

January 24 - News, Stock Analysis - Comments

Healthcare Careers That Require a Master’s Degree

Bristol-Myers Squibb Co (BMY) Agrees To Extend Research With Five Prime Therapeutics Inc (FPRX)

Bristol-Myers Squibb Co (NYSE:BMY) has opted to extend the research term of its discovery collaboration agreement with Five Prime Therapeutics Inc (NASDAQ......(read more)

January 5 - News, Stock Analysis - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider

After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences......(read more)

December 23 - News, Stock Analysis - Comments

Bristol-Myers Squibb Co (BMY) And Pfizer Inc. (PFE) Agree To $50 Million Loan To Portola Pharmaceuticals Inc (PTLA)

There is a need for additional funding towards the development and clinical studies of AndexXa, a new compound that is a prospective antidote for Factor......(read more)

December 20 - News, Stock Analysis - Comments

merger, businessman, greeting, handshake, hands, business, concept, handclasp, success, friendship, symbol, partnership, tone, cooperation, people, agree, welcome,

Bristol-Myers Squibb Company (BMY), Infinity Pharmaceuticals, Inc. (INFI) Team Up On Opdivo Combination Therapy

Bristol-Myers Squibb Co (NYSE:BMY) and Infinity Pharmaceuticals Inc. (NASDAQ:INFI) have recently entered into an agreement to commence a collaborative......(read more)

November 10 - News, Stock Analysis - Comments

Scout Daily Update: Core Durable Goods Down 21 Straight Months

STOCK NEWS Twitter Inc (NYSE:TWTR): reported Q3 EPS of $0.13 which beat estimates by 4 cents. Revenue of $616 million was up 8.2% which beat estimates......(read more)

October 27 - Earnings Report, Market Movers, News - Comments